Your Input, Please: ABA Blawg 100 Amici Nominations Due August 16

By Karen S. Lovitch, Theresa C. Carnegie

As the co-editors of Health Law & Policy Matters, we are pleased to report that our blog was recently ranked as the No. 1 Health Law Blog in LexBlog’s AmLaw 200 Blog Benchmark Report based on overall traffic. We could not have achieved this ranking without our readers so we would like to thank you for your continued support.  We will continue to work toward generating content that will help you stay abreast of legal and policy developments affecting the health care industry.

If you’ve enjoyed reading our blog, please note that nominations are now open for the Blawg 100 Amici, the American Bar Association’s list of top 100 best legal blogs.  These rankings are based on nominations (both the quantity and quality thereof), and we would greatly appreciate your support by nominating us via the ABA’s nomination form.  Nominations are due by Sunday, August 16.  You will have to provide some information, including your name and email address.  You will also have to input the Health Law and Policy Matters URL (which is /) and a link to a recent blog post (you can use this one: /2015/07/28/emerging-state-biosimilar-laws-reference-chart-and-five-issues-to-watch/, or any other post of your choosing).  You will also be asked to state why you are a “fan” of the blog in 500 words or less, and we have no problem if you opt for the “less” as long as you say something!

If you have any questions, please do not hesitate to contact us.  We thank you in advance for any support you can provide here.

Subscribe To Viewpoints

Published

Viewpoint Topics

Professionals

Authors

Karen S. Lovitch

Chair, Health Law Practice & Co-Chair, Health Care Enforcement Defense Practice

Karen advises industry clients on regulatory, transactional, operational, and enforcement matters. She has deep experience handling FCA investigations and qui tam litigation for laboratories and diagnostics companies.

Theresa C. Carnegie

Member

Theresa advises clients on all aspects of the pharmaceutical supply chain, including counseling industry stakeholders on a range of business, legal, transactional, and compliance matters. She provides clients with strategic counseling and creative business modeling that considers legal restrictions and regulatory risk in light of innovation and business goals.